initial public offerings (IPOs) trading on American exchanges

Wednesday, January 13, 2021

AbCellera Biologics (ABCL) began trading on the Nasdaq on Fri 11 Dec 20

  • Sector(s): Healthcare
  • Industry: Biotechnology
  • Full Time Employees: 174
  • Founded in 2012 
  • Headquartered in Vancouver, Canada
  • http://www.abcellera.com



AbCellera Biologics  CEO Carl Hansen on CNBC on Wed 1/13/21

No comments:

Post a Comment